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Unravelling the effects of 
mechanical physiological 
conditioning on cardiac adipose 
tissue-derived progenitor cells  
in vitro and in silico
Aida Llucià-Valldeperas1, Ramon Bragós2, Carolina Soler-Botija1, Santiago Roura1,3,  
Carolina Gálvez-Montón1, Cristina Prat-Vidal1, Isaac Perea-Gil1 & Antoni Bayes-Genis1,4,5
Mechanical conditioning is incompletely characterized for stimulating therapeutic cells within the 
physiological range. We sought to unravel the mechanism of action underlying mechanical conditioning 
of adipose tissue-derived progenitor cells (ATDPCs), both in vitro and in silico. Cardiac ATDPCs, grown on 3 
different patterned surfaces, were mechanically stretched for 7 days at 1 Hz. A custom-designed, magnet-
based, mechanical stimulator device was developed to apply ~10% mechanical stretching to monolayer 
cell cultures. Gene and protein analyses were performed for each cell type and condition. Cell supernatants 
were also collected to analyze secreted proteins and construct an artificial neural network. Gene and 
protein modulations were different for each surface pattern. After mechanostimulation, cardiac ATDPCs 
increased the expression of structural genes and there was a rising trend on cardiac transcription factors. 
Finally, secretome analyses revealed upregulation of proteins associated with both myocardial infarction 
and cardiac regeneration, such as regulators of the immune response, angiogenesis or cell adhesion. To 
conclude, mechanical conditioning of cardiac ATDPCs enhanced the expression of early and late cardiac 
genes in vitro. Additionally, in silico analyses of secreted proteins showed that mechanical stimulation of 
cardiac ATDPCs was highly associated with myocardial infarction and repair.
The heart is a mechanically-active organ that dynamically senses and responds according to its local environ-
mental milieu. This environment fluctuates on a beat-to-beat basis, with additional modulation from respiratory 
activity, postural changes and physical activity; moreover, this milieu is further enriched by physiological (e.g., 
pregnancy, endurance training) and pathological (e.g., pressure or volume overload) conditions1. The heart is not 
a simple pump; it detects changes in mechanical demands and adjusts its performance via changes in heart rate 
and stroke volume2. These regulatory processes are encoded and maintained intramyocardially. However, the 
mechanisms underlying cardiac mechanosensitivity are poorly understood3.
It is well known that mechanical stretch improves contractility4, enables growth factor secretion, and pro-
motes calcium handling in cardiac myocytes. Additionally, mechanical stretch alters extracellular matrix (ECM) 
synthesis in cardiac fibroblasts5. Generally, mechanical tension promotes heart muscle survival by regulating cell 
alignment, elongation, hypertrophy, and differentiation6.
In contractile tissues, functional properties are directly related to cellular orientation and elongation. Thus, cell func-
tion critically depends on the interaction between multiple guidance cues, such as topography7. On the other hand, the 
connective tissue provides passive support for regulating heart tensile strength and stiffness. Indeed, its endomysial part 
provides support for heart compliance and protection against overstretch thanks to its laminae organization8.
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Nevertheless, there is no evidence on mechanical conditioning effects on adipose tissue-derived progeni-
tor cells (ATDPCs), which are currently gaining momentum for clinical translation in the context of a variety 
of tissue regeneration trials such as APOLLO (NCT00442806)9, ADVANCE (NCT01216995), and PRECISE 
(NCT00426868)10 for myocardial infarction (MI) repair. In particular, ATDPCs are reported to exercise bene-
ficial effects through two mechanisms: cell differentiation and paracrine signaling11. Indeed, ATDPCs-derived 
secretome has been associated with angiogenesis, immunomodulation, and wound healing12. In the same line, 
proteome analysis can generate Artificial Neural Networks (ANN), which evaluate possible relations among pro-
teins sets inside the network and quantify this probability.
This study aimed to provide a better understanding of the effects of mechanical conditioning on cardiac 
ATDPCs. To that end, we designed and constructed a magnet-based, mechanical stimulator device to apply ~10% 
mechanical stretching to in vitro cultures of cell monolayers. We then cultured ATDPCs on 3 different patterned 
surfaces and continuously applied mechanical stretching to explore their gene expression and secretome. Finally, 
based on that data, we constructed and analyzed an ANN in silico.
Results
Mechanical Stimulation Validation. The dimensions of the final structure (Fig. 1A) are specified in 
Fig. 1C (in mm). The pool that held the cell monolayer had a surface area of 1 × 1 cm and a depth of 1 mm. The 
bottom of the pool was a transparent film of 0.5 mm that allowed microscopic observation and the imprint of a 
pattern. The PDMS had been cured at room temperature and had a Young’s modulus of 1.3 MPa13, close to physi-
ological levels14. Considering these parameters, a force of 0.104 N (10.6 gf) was required to provide a strain of 1%, 
and a force of 1.04 N (106 gf) provided a strain of ~10%.
Strain was measured with the Matlab (Mathworks) ImgTool utility display. When the moving magnet was 
positioned next to the silicone construct, both sides of the pool underwent a longitudinal deformation of ~10%, 
and the transverse borders of the pool underwent negligible deformation (Fig. 1D). The stretch was transferred 
from the substrate to the cell monolayer, as evidenced by the microscale strain transfer characterization (data not 
shown). Moreover, the Fort25 sensor (Fig. 1B) detected a trapezoidal waveform with a rise and fall times of 100 
ms, mimicking the pressure cycle shape in the heart (Fig. 1E,E′).
Gene expression analysis. After 7 days of mechanical conditioning, cells grown on different patterned 
surfaces (vertical, horizontal, or smooth) were harvested, and RNA was isolated for gene expression experiments. 
We found that mechanical stretching modulated gene expression in both cardiac and subcutaneous ATDPCs. 
Moreover, the modulations were strongly dependent on the surface pattern (Table 1 and Supplementary Table 1). 
After mechanical stimulation, cardiac ATDPCs significantly increased expression of structural genes and evi-
denced a rising trend in cardiac transcription factors (Table 1). Structural genes, such as cardiac troponin I (cTnI) 
and α-actinin, were significantly upregulated in cells grown on horizontal (P = 0.044) and smooth (P = 0.001) 
surfaces, respectively. Additionally, there was an augmenting trend for GATA-4 of ∼3-fold in cells grown on 
vertical patterned surfaces (P = 0.068), and Tbx5 of ∼1.4-fold in cells grown on horizontal patterned surfaces 
(P = 0.065). On the other hand, in subcutaneous ATDPCs, mechanostimulation augmented Tbx5 gene expression 
∼2-fold on vertical patterned surfaces (P = 0.007), and SERCA2 expression presents an increasing tendency of 
∼1.5-fold on horizontal patterned surfaces (P = 0.079) (Supplementary Table 1).
Protein expression analysis. Gene modulations observed were also translated at the protein level; pro-
tein expression profiles of the main cardiac markers in non-conditioned controls and mechanically-stimulated 
ATDPCs grown on each patterned surface are shown in Fig. 2. In both cell lines and in all patterns and conditions, 
Cx43 was distributed throughout the cytoplasm, but particularly at the plasma membrane and at the cell poles 
(Fig. 2 upper rows). SERCA2 and α-actinin were observed in the cytoplasm of cells but without an appreciable 
mature sarcomere organization (Fig. 2 middle and lower rows, respectively). MEF2A and GATA-4 are nuclear 
markers (Fig. 2 middle and lower rows, respectively); and GATA-4 protein expression was detected only in the 
nuclei of cardiac ATDPCs, not in subcutaneous ATDPCs (Fig. 2 lower rows).
Cell monolayers showed some degree of alignment with the different surface patterns; while cells were ran-
domly distributed on smooth surfaces, mainly dictated by cell density. Fluorescence intensities were normalized 
and measured to quantify protein abundance in each condition. Protein increments observed at gene level were 
revealed and corroborated at protein level (Table 2).
Secretome analysis. About 200 proteins were identified in the supernatants collected from control and 
mechanically-stimulated cardiac and subcutaneous ATDPCs on each patterned surface. Statistical analyses 
revealed differential expression of several proteins (Table 3), and some proteins were identified in different 
secretomes (Fig. 3A,B).
The ANN analysis (Table 4) showed that most secretomes were consistently associated with MI (~80% pre-
dictability). Secretomes from cardiac ATDPCs seeded on smooth surfaces and subcutaneous ATDPCs seeded 
on horizontal surfaces were also associated with cardiac regeneration (~70–80% predictability) and its two 
sub-functions, angiogenesis and proliferation. Further, stimulated cardiac and subcutaneous ATDPCs grown on 
vertical and horizontal surfaces, respectively, were more related to MI and its two sub-functions, inflammation 
and left ventricle (LV) ECM remodeling, than ATDPCs grown in the other conditions. The 3 scenarios most 
closely related to MI and cardiac regeneration were cardiac ATDPCs mechanically stimulated on vertical and 
smooth surfaces, and subcutaneous ATDPCs mechanically stimulated on horizontal surfaces. In these 3 condi-
tions, secreted proteins were primarily involved in ECM remodeling, inflammation, and proliferation (Table 3, 
Fig. 3C–E).
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Mechanostimulated cardiac ATDPCs grown on vertical surfaces also differentially expressed proteins that 
regulated the immune response (complement C3 protein), ECM assembly/disassembly (tissue inhibitor of met-
alloproteinase 1 [TIMP-1], vimentin, and collagen type VI α-1 chain), angiogenesis (fibronectin [FN]), and cell 
adhesion (FN, collagen type VI α-1 chain).
Figure 1. Mechanical stimulator design, characterization, and validation. (A) 3D view of the cell support 
system as reported in the patent PCT/EP 2012/061224. Two lateral structures, each containing an embedded 
magnet (part no. 126), are designed to exert pulling force on a thinner, central segment, which contains a 
rectangular cavity (pool, part no. 114) that holds a cell culture solution for growing the cell monolayer. (B) The 
Fort25 force transducer is shown, with a magnet attached to the sensor and aligned with the moving magnet; 
(B′) detail of the magnet attached to the force sensor lever. (C) Dimensions (in mm) of the cell support system 
as reported in the patent PCT/EP 2012/061224. The central segment containing the pool is the thinnest 
section of the whole structure; thus, it undergoes the greatest deformation. (D) Longitudinal and transverse 
measurements (in pixels) of the inner borders of the pool shows a ~10% elongation of the longitudinal borders. 
(E) Capture of the output differential voltage detected with the Fort25 sensor. (E′) The rise time slope is shown 
on a magnified scale. The rise and fall times were set to 100 ms, for a rough imitation of the ventricular pressure 
waveform. The small oscillations represent detection of residual, 50 Hz interference from the mains voltage 
supply (background noise).
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Mechanostimulated cardiac ATDPCs grown on smooth surfaces also differentially expressed proteins 
involved in ECM assembly/disassembly (TIMP-1, matrix metalloproteinase 2 [MMP-2], collagen type VI α-1 
chain), angiogenesis (MMP-2), immune response (pentraxin-related protein 3 [PTX3]), cardiomyogenesis and 
proliferation (follistatin-related protein 1 [FSTL1]), and cell adhesion (collagen type VI α-1 chain).
And mechanostimulated subcutaneous ATDPCs seeded on horizontal surfaces expressed proteins for ECM 
assembly/disassembly (α-2-macroglobulin [α-2-M]), transcription regulation and cell proliferation (Thioredoxin 
[TXN]), and cell adhesion (collagen type VI α-1 chain).
Based on a topological analysis, effector proteins involved in MI and cardiac regeneration were observed in all 
secretomes (except cardiac ATDPCs cultured on horizontal surfaces) (Table 3). Both cardiac and subcutaneous 
ATDPCs expressed relevant MI and/or cardiac regeneration effectors, such as TIMP-1, FSTL1, or FN. In addition, 
secretome proteins were directly linked to other effector proteins, such as matrix metalloproteinases (MMP-1, 
MMP-2, MMP-3, MMP-9, MMP-14, MMP-15), growth factors (TGF-β1 [P01137], FGF-2 [P09038], and IGF-1 
[P05019]), and chemokines (CXCR4 [P61073], CXCL12 [P48061], CXCL8 [P10145]), among others (Fig. 3C–E).
Immunostainings for some ECM proteins confirmed secretome data (Table 3). Fibronectin protein expres-
sion was increased in mechanically stimulated cardiac ATDPCs cultured on vertical surfaces, and vimentin pro-
tein expression was increased in mechanically stimulated subcutaneous ATDPCs cultured on smooth surfaces 
(Fig. 3F,G).
Of note, some proteins were only detected after mechanical stimulation, such as cartilage oligomeric matrix 
protein (P49747) or glucose-6-phosphate 1-dehydrogenase (P11413).
Discussion
It is well known that cells respond to mechanical forces by activating specific genes and signaling pathways that 
allow them to adapt to their physical environment. Here we conceived and developed a novel, custom-designed, 
magnet-driven, mechanostimulation device that mimics physiological heart contractions and it was tested in in 
vitro and in silico environments.
Cardiac ATDPCs are an attractive source for cell therapies; they can be readily obtained, they constitutively 
express the primary cardiac genes, they have immunomodulatory properties, and they can differentiate to both 
cardiac and endothelial lineages, as shown when implanted over the infarcted murine myocardium11,15–18. Our 
strategy was to use biophysical stimulation to induce transdifferentiation of cardiac ATDPCs to the cardiovascu-
lar lineage. First, we found that 7 days of mechanical stimulation modulated gene expression in cardiac ATDPCs 
seeded on all 3 surface patterns. Moreover, we found that the surface pattern influenced cardiac gene modula-
tion. Indeed, early transcription factors were upregulated in cardiac ATDPCs grown on vertical and horizontal 
patterns, and structural genes were increased in ATDPCs grown on horizontal and smooth patterns. The surface 
pattern can assist with the cell–cell contact, which is essential for a proper cardiac differentiation. Then, after the 
cell–cell interaction is reached; the differentiation success would also be determined by other factors, such as 
culture medium or stretching19. In the same line, biophysical cues can be sensed and transduced into intracellular 
responses to regulate downstream gene expression and stem cell fate, a process known as mechanotransduction20. 
In addition, mechanical forces might have the potential to directly regulate the cell fate through modulating 
calcium signals21. On one hand, mechanical stress activates stretch-activated channels, which causes cytoskel-
etal remodeling and regulates cell proliferation22. On the other hand, mechanical stress on cells attached to the 
ECM induces integrin rearrangement, and the subsequent differentiation response23. Wnt and MAPK signaling 
pathways are the most frequent; however, others have been described to regulate stem cell differentiation, such 
Sample Tbx5 MEF2A GATA-4 α-actinin Cx43 SERCA2 β-MyHC cTnI
Vertical
cardiac ATDPCs 
Con 0.003 ± 0.001 0.089 ± 0.018 0.428 ± 0.196 2.445 ± 1.089 0.705 ± 0.253 0.397 ± 0.237 0.095 ± 0.049 0.693 ± 0.555
cardiac ATDPCs MS 0.004 ± 0.002 0.169 ± 0.089 1.209 ± 0.378 2.326 ± 1.109 1.371 ± 0.949 0.551 ± 0.413 0.181 ± 0.114 0.964 ± 0.620
Ratio MS/Con 1.430 1.901 2.822 0.951 1.945 1.386 1.912 1.391
P-value Con vs MS 0.653 0.410 #0.068 0.753 0.517 0.756 0.443 0.940
Horizontal
cardiac ATDPCs 
Con 0.004 ± 0.000 0.031 ± 0.007 0.030 ± 0.005 0.180 ± 0.011 0.150 ± 0.043 0.046 ± 0.007 7.8·10
−6 ± 5.4·10−6 5.1·10−6 ± 2·10−6
cardiac ATDPCs MS 0.005 ± 0.000 0.033 ± 0.002 0.035 ± 0.003 0.286 ± 0.064 0.139 ± 0.042 0.063 ± 0.005 1.8·10−5 ± 1.5·10−5 1.4·10−5 ± 1.9·10−6
Ratio MS/Con 1.405 1.067 1.179 1.587 0.926 1.384 2.320 2.672
P-value Con vs MS #0.065 0.854 0.397 0.181 0.865 0.110 0.419 *0.044
Smooth
cardiac ATDPCs 
Con 0.001 ± 0.000 0.029 ± 0.007 0.050 ± 0.008 0.213 ± 0.010 0.228 ± 0.100 0.091 ± 0.015 1.7·10
−5 ± 1.6·10−5 7.6·10−6 ± 5.1·10−6
cardiac ATDPCs MS 0.001 ± 0.000 0.045 ± 0.014 0.067 ± 0.013 0.362 ± 0.018 0.262 ± 0.101 0.127 ± 0.019 2·10−5 ± 1.5·10−5 1.2·10−5 ± 1.2·10−5
Ratio MS/Con 1.716 1.537 1.326 0.891 1.151 1.390 1.182 1.547
P-value Con vs MS 0.217 0.404 0.312 *0.001 0.817 0.198 0.848 0.662
Table 1. Relative expression of cardiac markers for each surface condition in cardiac ATDPC cultures. 
Gene expressions were analyzed in duplicate for comparisons between mechanically stimulated (MS) and 
control (Con) samples. Relative expression (2−ΔCT) and fold-changes in expression (MS/Con) are shown for 
cardiomyogenic genes. Values were normalized to GAPDH expression and represent the mean ± SEM for at 
least 4 independent experiments. *P < 0.05 (significant) and #P < 0.10 (trend).
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Figure 2. Protein expression profiles after mechanical stimulation. Immunohistochemical staining shows 
expression of proteins in cardiac (left) and subcutaneous (right) ATDPCs grown on vertical, horizontal, and 
smooth patterned surfaces, as indicated (diagrams in the top, centers indicate surface patterns with respect to 
the magnets in the cell support system). Control (first and third columns) and mechanostimulated (second and 
fourth columns) were stained, as indicated, to show expression of (top rows) actin F (phalloidin staining, red) 
and Cx43 (green); (center rows) SERCA2 (red) and MEF2 (green); and (bottom rows) sarcomeric α-actinin 
(red) and GATA-4 (green). Nuclei were counterstained with DAPI (blue) in A–D,K,L,M–P,W,X,Y–AB,AI,AJ). 
Scale bars = 50 µm.
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6SCIEnTIfIC REPORts |  (2018) 8:499  | DOI:10.1038/s41598-017-18799-5
as TGF-β1, Notch, Smad and Hedgehog signaling pathways24. Taken together, mechanical stimuli affect both 
proliferation and differentiation, although the complete scheme with all molecular pathways involved remains to 
be elucidated.
Mechanical conditioning enhanced the expression of transcription factors (GATA-4 and Tbx5) and struc-
tural genes (cTnI and α-actinin) in cardiac ATDPCs. On the one hand, GATA-4 is one of the earliest cardiac 
transcription factors expressed, it is involved in heart development and early cardiac differentiation25, and it 
directly interacts with MEF2 to be co-activators in cardiac myogenesis26. Additionally, Tbx5 is crucial for proper 
cardiovascular development, and it synergistically interacts with GATA-4 and Nkx2.5 transcription factors27. 
On the other hand, cTnI and α-actinin are structural proteins located in the sarcomere, which are responsible 
for cell alignment. cTnI, the inhibitory subunit of the troponin trimeric complex, binds to actin thin myofila-
ments to secure the actin-tropomyosin complex in place, and it regulates muscle contraction28. The cytoskeletal 
protein α-actinin cross-links actin filaments and play important roles in cytoskeleton organization and muscle 
contraction29.
We found that the mechanically-stimulated ATDPC secretome was associated with both MI and cardiac 
regeneration. These functions appear at first antagonistic, but ultimately, they may reflect the two faces of Janus. 
Certainly, most proteins participated in myocardial structure and function, irrespective of whether the conditions 
were destructive (MI) or constructive (cardiac regeneration). Interestingly, some transcription factors, such as 
GATA-4, modulate the paracrine role of cells to support their angiomyogenic potential and cardioprotective 
effects30. Additionally, the patterned surface had a key role to influence the secretion of some factors through 
the mechanotransduction20, and it could be beneficial to design the most appropriate scenarios according to the 
ultimate goal (i.e. regeneration of the myocardium). The most relevant proteins differentially expressed by mech-
anostimulation are discussed next.
Complement component C3 activation facilitates myocardial preservation and regeneration through the 
mobilization and activation of cardiac stem/progenitor cells to promote myocardial regeneration after MI31.
LV ECM remodelling post-MI involves MMP activity at every step. MMP activity is regulated by α-2-M and 
TIMPs. MMP-2 is a proteolytic enzyme, especially secreted under hypoxic conditions, that increases the number 
of migrating progenitor cells, particularly cardiac stem cells, to damaged tissue32,33. TIMP-1 inhibits most MMPs, 
Sample MEF2A GATA-4 α-actinin Cx43 SERCA2 actinF
Vertical
cardiac ATDPCs Con 1.125 ± 0.093 0.979 ± 0.114 0.958 ± 0.088 0.449 ± 0.071 1.325 ± 0.110 0.649 ± 0.069
cardiac ATDPCs MS 1.289 ± 0.179 0.729 ± 0.016 0.705 ± 0.024 0.678 ± 0.028 2.065 ± 0.184 0.729 ± 0.019
Ratio MS/Con 1.146 0.745 0.737 1.509 1.559 1.123
P-value Con vs MS 0.423 *0.050 *0.016 *0.002 *0.002 0.301
Horizontal
cardiac ATDPCs Con 1.150 ± 0.146 0.654 ± 0.024 1.113 ± 0.014 0.448 ± 0.117 1.213 ± 0.054 1.233 ± 0.270
cardiac ATDPCs MS 0.732 ± 0.071 0.662 ± 0.020 1.499 ± 0.051 1.080 ± 0.020 1.521 ± 0.080 1.425 ± 0.044
Ratio MS/Con 0.636 1.013 1.346 2.409 1.254 1.156
P-value Con vs MS *0.011 0.880 *0.000 *0.000 *0.043 0.504
Smooth
cardiac ATDPCs Con 0.435 ± 0.012 0.725 ± 0.070 1.126 ± 0.086 0.858 ± 0.068 0.435 ± 0.017 1.330 ± 0.095
cardiac ATDPCs MS 0.639 ± 0.015 0.910 ± 0.088 2.568 ± 0.215 1.794 ± 0.160 0.975 ± 0.027 5.190 ± 0.617
Ratio MS/Con 1.469 1.255 2.281 2.091 2.242 3.904
P-value Con vs MS *0.000 0.123 *0.000 *0.000 *0.000 *0.000
Vertical
subcutaneous 
ATDPCs Con 0.841 ± 0.047 NA 1.403 ± 0.169 0.776 ± 0.147 0.613 ± 0.048 0.751 ± 0.108
subcutaneous 
ATDPCs MS 0.784 ± 0.096 NA 1.535 ± 0.367 1.048 ± 0.110 0.508 ± 0.043 1.677 ± 0.123
Ratio MS/Con 0.932 1.094 1.349 0.828 2.232
P-value Con vs MS 0.562 0.726 0.197 0.110 *0.000
Horizontal
subcutaneous 
ATDPCs Con 0.718 ± 0.058 NA 1.223 ± 0.043 0.972 ± 0.013 1.572 ± 0.047 1.287 ± 0.095
subcutaneous 
ATDPCs MS 0.711 ± 0.017 NA 1.172 ± 0.043 1.005 ± 0.037 1.178 ± 0.059 1.406 ± 0.057
Ratio MS/Con 0.990 0.959 1.034 0.749 1.093
P-value Con vs MS 0.891 0.492 0.405 *0.000 0.264
Smooth
subcutaneous 
ATDPCs Con 0.662 ± 0.048 NA 1.194 ± 0.099 0.752 ± 0.095 1.542 ± 0.366 1.955 ± 0.254
subcutaneous 
ATDPCs MS 0.965 ± 0.063 NA 1.121 ± 0.080 1.520 ± 0.112 2.377 ± 0.158 2.823 ± 0.229
Ratio MS/Con 1.457 0.938 2.022 1.542 1.445
P-value Con vs MS *0.004 0.568 *0.000 #0.052 *0.018
Table 2. Protein quantification determined from immunostaining of the main cardiac markers for each 
condition and cell type. Fluorescence intensity values were normalized to DAPI intensity and are shown as the 
mean ± SEM. Con: control, MS: mechanostimulated. *P < 0.05 (significant) and #P < 0.10 (trend). NA, not 
applicable.
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with high affinity for MMP-9, which is released a few hours after a MI34. Further, α-2-M is a homotetramer 
that can inhibit proteinases, but it is also a secreted glycoprotein present in the plasma of patients with heart 
failure35,36. Consequently, in most of the tested conditions, modulation of α-2-M and TIMP-1 would constrain 
adverse cardiac remodelling and assist cardiac restoration.
Fibronectin (FN) is an ECM protein highly expressed during early development and re-appears after patho-
logical injury. It is required for heart regeneration, because it is involved in tissue repair processes, and it regulates 
inflammatory cell function, cell proliferation, cell migration, cellular dedifferentiation, fibrosis, and vasculariza-
tion37. In the MI setting, FN is produced by ischaemic cardiomyocytes, particularly from the epicardium, and by 
local fibroblasts38. Vimentin maintains cell integrity, and its increased content in both cardiomyocytes and new 
small blood vessels wall has been associated to tissue regeneration39.
Collagen type VI α-1 chain is an ECM molecule with cytoprotective functions. It counteracts apoptosis 
and oxidative damage, regulates autophagy and cell differentiation, and even contributes to the maintenance of 
stemness40. Its presence is linked to early remodelling after acute MI, being a marker of collagen denaturation, 
although it also contributes to ECM formation at the infarcted zone41. Thus, collagen type VI α-1 chain is asso-
ciated with both MI and cardiac regeneration. We found that it was increased in cardiac ATDPCs and decreased 
in subcutaneous ATDPCs.
PTX3 is highly expressed in the heart, rapidly expressed during primary local activation of innate immunity 
and inflammation, and it is considered a cardiac prognosis biomarker42. Cardiac microenvironment in vivo and 
mechanical stretching in vitro may enhance PTX3 secretion from ATDPCs to assist myocardial regeneration, as 
previously described43.
FSTL1 is involved in heart development and plays a cardioprotective role44,45. FSTL1 attenuated hypertrophy 
following a pressure overload46, it prevented myocardial injury in MI and ischemia/reperfusion murine or swine 
models44,47, and it modulated vascular remodelling in response to injury48. Recently, the application of human 
FSTL1 protein in an epicardial patch induced cardiomyocyte proliferation and promoted regeneration, improving 
cell survival and cardiac function in mouse and swine MI models44.
In conclusion, mechanical stimulation of cardiac ATDPCs mimics the cardiac structural milieu. This con-
dition enhanced the expression of early and structural cardiac genes in vitro and promoted the secretion of car-
dioprotective factors as evidenced by the secretome analyses. In silico analyses of secreted proteins showed that 
mechanical stimulation of cardiac ATDPCs was highly associated with MI and repair. Taken together, mechanical 
pre-conditioning on patterned surfaces prior to cell delivery emerges as a promising therapeutic strategy to drive 







Complement C3 P01024 1.017 Inflammation 11
Tissue inhibitor of metalloproteinases 1 (TIMP-1) P01033 0.911 LV ECM remodelling 4
Fibronectin (FN) P02751 1.004 LV ECM remodelling 4
Vimentin P08670 0.974 Intermediary 8
Collagen type VI α-1 chain P12109 1.169 LV ECM remodelling 7
Cardiac ATDPCs 
horizontal Stromal interaction molecule 2 Q9P246 de novo — 0
Cardiac ATDPCs 
smooth
Tissue inhibitor of metalloproteinases 1 (TIMP-1) P01033 1.002 LV ECM remodelling 4
Matrix metalloproteinase 2 (MMP-2) P08253 1.036 LV ECM remodelling 20
Collagen type VI α-1 chain P12109 1.097 LV ECM remodelling 7
Pentraxin-related protein 3 (PTX3) P26022 1.166 Intermediary 1
Follistatin-related protein 1 (FSTL1) Q12841 0.994 Proliferation 4
Subcutaneous 
ATDPCs vertical
Tissue inhibitor of metalloproteinases 1 (TIMP-1) P01033 1.063 LV ECM remodelling 4
Fibronectin (FN) P02751 1.012 LV ECM remodelling 4
Matrix metalloproteinase 2 (MMP-2) P08253 0.964 LV ECM remodelling 20




α-2-macroglobulin (α-2-M) P01023 1.008 Intermediary 10
Thioredoxin (TXN) P10599 1.038 Intermediary 5
Collagen type VI α-1 chain P12109 0.824 LV ECM remodelling 7
Subcutaneous 
ATDPCs smooth
Collagen type I α-1 chain P02452 1.031 Intermediary 7
Collagen type I α-2 chain P08123 1.017 Intermediary 5
Vimentin P08670 1.006 Intermediary 8
Complement C1s subcomponent P09871 1.089 — 0
Transforming growth factor-β-induced protein ig-h3 Q15582 0.993 — 0
Nuclear pore complex protein (Nup205) Q92621 1.009 Intermediary 2
Table 3. Results from the pairwise, trimmed, mean normalization analysis for each condition. Proteins that 
showed significant differential expression in mechanostimulated (MS) and control (Con) cells are shown with 
their name and UNIPROT code. The relative protein abundance is shown in the “MS vs. Con” column. The 
“Effector” column indicates the protein category. The “# Linked Effectors” column indicates the number of 
effector proteins linked to the protein of interest.
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recovery of cardiac function after MI. Therefore, further in vivo experimentation with mechanically conditioned 
cells will be highly recommended to finally unravel the effects derived from the mechanical stimulation.
Methods
Custom-designed, magnet-based, mechanical stimulator and cell support device. The design of 
the cell support system is shown in Fig. 1A (submitted in a patent application: PCT/EP 2012/061224). The chosen 
polymer was polydimethylsiloxane (PDMS; Sylgard 184, Dow Corning Corp.), which has an elastic modulus in 
the range of 1.3–3 MPa relative to preparation temperature.
The prototypes of the cell support system were composed of moulds made of poly(methyl methacrylate) 
(PMMA). The lower parts of both moulds held embedded magnets that helped to maintain the position of the 
magnets that we embedded in the PDMS pieces during the curing process. The six-piece mould could hold a 
pattern cast in order to transfer a vertical (perpendicular to the stretching force), or horizontal line pattern (par-
allel to the stretching force) onto the bottom of the pool section, where cells were seeded. The regular pattern 
was imprinted into the PDMS using a planed, ruled diffraction grating (1250 grooves/mm; 05RG150-1250-2, 
Newport) using a high-precision and consistent polyvinylsiloxane (Affinis, Coltène Whaledent), as previously 
described15. The magnets were selected to fit into the structure and to provide the required forces. The selected 
magnet model embedded into the PDMS cell support was a 6 × 2 × 4 mm nickel-plated neodymium magnet from 
Supermagnete (model Q-06-04-02-HN). The selected magnet model for the external driving forces (two magnets, 
one placed next to the culture plate and the other on the moving arm) were 10 × 10 × 5 mm nickel-plated neo-
dymium magnets, also from Supermagnete (model Q-10-10-05-N). Two inner, transverse slots next to the pool 
were created to hold electrodes for electrical stimulation or simultaneous electromechanical stimulation.
The current prototype comprised up to 6 culture plates that can be placed in a support made with a sand-
wich structure of laser cut PMMA and printed circuit board (FR7) pieces, which hold the fixed magnets. The 6 
driving magnets were mounted in an aluminium bar, which was moved with a linear servomotor (LM 2070-040-
11, Faulhaber). The motor was driven by a MCLM-3006-S motor controller (Faulhaber), which was operated 
through a RS-232 port by a LabView (National Instruments) application. Through the user interface, one could 
programme the frequency of the mechanical stimulation, its duty cycle, the number of pulses, and the pulse 
amplitude (magnet excursion).
Figure 3. Secretome analysis. (A,B) Venn’s diagrams of differentially expressed proteins in (A) cardiac 
ATDPCs and (B) subcutaneous ATDPCs. (C–E) Protein networks for (C) cardiac seeded on vertical patterned 
surfaces, (D) subcutaneous ATDPCs seeded on horizontal patterned surfaces, and (E) cardiac ATDPCs grown 
on a smooth surface. Red octagons are secretome proteins; red diamonds are secretome proteins that are also 
effectors of MI or cardiac regeneration; yellow circles are effectors of MI or cardiac regeneration that are linked 
to the secretome proteins; the blue circle indicates a protein included in the Gene Ontology (GO) terms that was 
linked to the indicated secretome protein; and green circles indicate proteins or effectors linked to the secretome 
proteins. (F) Fibronectin protein expression (green) in mechanically stimulated cardiac ATDPCs grown on 
vertical patterned surfaces. (G) Vimentin protein expression (green) in mechanically stimulated subcutaneous 
ATDPCs grown on smooth surfaces. Nuclei were counterstained with DAPI (blue). Scale bars = 50 µm.
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Initially, we chose a 1-Hz trapezoidal waveform with a 50% duty cycle. The rise and fall times of the waveform 
were programmed in the motor controller to occur over an interval of 100 ms, which roughly imitated the shape 
of the pressure cycle in the heart49. To assess the cycle shape, we assumed that the central part of the cell support 
would deform according to Hooke’s law (deformation is proportional to the force applied). Therefore, we used a 
force transducer (WPI-Fort25) to measure the force by attaching a magnet to the sensing lever (Fig. 1B,B′); this 
magnet was like the magnets embedded in the cell support.
Additionally, to evaluate the cell monolayer deformation and its uniformity along the structure, images were 
captured in the relaxed and maximum strain positions at a given force. Lengths were measured with the distance 
measurement tool in the Matlab (Mathworks) ImgTool utility display.
Microscale strain transfer characterization was used to confirm the transference from the substrate to the 
cell monolayer according to Simmons et al.50. Briefly, random cell morphologies were adequate fiducial markers 
to use conventional image correlation algorithms on the paired-paired images before and after stretching, using 
PIVLAB51.
Human ATDPC isolation and culture. Human ATDPCs were isolated from cardiac (cardiac ATDPCs) 
and subcutaneous (subcutaneous ATDPCs) adipose tissues collected from patients undergoing cardiac sur-
gery. Informed consent was obtained from all patients, the study protocol was approved by the local Ethics 
Committee (Germans Trias i Pujol University Hospital Ethics Committee), and it conformed to the princi-
ples of the Declaration of Helsinki. Adipose tissue biopsy samples were harvested and processed as previously 
described11,15,16 (see Suppl Materials for details).
Briefly, 3 × 104 ATDPC cells were seeded into the culture pool of each PDMS construct one day before stim-
ulation. The PDMS culture pools had 3 different surface patterns: perpendicular to the stretching force (vertical 
pattern), parallel to the stretching force (horizontal pattern), and without a pattern (smooth surface). The mech-
anostimulation protocol consisted of 10% stretching at 1 Hz for 7 days. This experiment was repeated a minimum 
of 4 times (with at least 3 replicates each) for the in vitro experimentation (gene and protein analyses), and 3 times 
for secretome analyses. Non-stimulated cells were used as a control group for the mechanical conditioning, and 
subcutaneous ATDPCs were used as a control group for cardiac ATDPCs. Cells not attached to the surface or with 
an atypical phenotype or morphology, and also PDMS constructs without the appropriate stiffness parameters, 
were discarded.
Quantitative real-time RT-PCR and immunocytofluorescence. Total RNA was isolated from cardiac 
and subcutaneous ATDPCs with the AllPrep RNA/Protein Kit (Qiagen). cDNA was synthesized using random 
hexamers (Qiagen) and the iScript™ One-Step RT-PCR Kit (BioRad Laboratories), according to the manufac-
turer’s protocol. cDNA was preamplified with the TaqMan® PreAmp Master Mix Kit (Applied Biosystems); 
then, the solutions were diluted 1:5 with RNase-free water (see Suppl Material for more details on RT-PCR and 
immunocytofluorescence).
Supernatant collection and proteome construction. Cell seeding onto PDMS constructs was per-
formed one day before beginning the 7-day mechanical stimulation. On day 5 of stimulation, growth media was 
replaced with the equivalent volume of serum-free media, and 48 h later (on day 7), the supernatant containing 
secreted proteins was collected, frozen, and stored at −80 °C for further analysis. The supernatants were obtained 





death LV ECM remodelling
Cardiac ATDPCs vertical 73.28% 58.38% 21.04% 84.30%
Cardiac ATDPCs horizontal 4.96% 13.20% 57.91% 21.92%
Cardiac ATDPCs smooth 79.07% 49.59% 11.96% 88.26%
Subcutaneous ATDPCs vertical 81.84% 32.05% 5.24% 82.73%
Subcutaneous ATDPCs horizontal 74.34% 70.17% 29.99% 71.01%






Cardiac ATDPCs vertical 15.94% 26.80% 5.32% 14.04% 5.39%
Cardiac ATDPCs horizontal 5.29% 5.07% 7.44% 19.33% 5.05%
Cardiac ATDPCs smooth 83.10% 44.31% 5.40% 16.96% 69.55%
Subcutaneous ATDPCs vertical 18.72% 11.19% 5.46% 9.32% 8.97%
Subcutaneous ATDPCs horizontal 70.74% 56.72% 10.64% 26.37% 15.41%
Subcutaneous ATDPCs smooth 39.29% 57.89% 6.64% 7.20% 6.08%
Table 4. Artificial Neural Network prediction values for myocardial infarction (MI) and cardiac regeneration 
functions. Bold values are the most relevant for each cell type and condition.
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smooth patterned surfaces). The secreted proteins were isolated and sequenced (see Suppl Material for more 
details on proteome obtainment).
Protein peptides were identified with the Proteome Discoverer software suite (v1.4.1.14, Thermo Fisher 
Scientific) and the Mascot search engine (v2.4, Matrix Science52). A sequence comparison analysis was conducted 
with an in-house-generated database, which contained all proteins that corresponded to the human database 
(Uniprot, October 2015), plus the most common contaminants, as previously described53. We used a precursor 
ion mass tolerance of 7 ppm at the MS1 level, and we allowed up to 3 miscleavages for trypsin. The fragment ion 
mass tolerance was set to 0.5 Da. Oxidation of methionine and protein acetylation at the N-terminus were defined 
as variable modifications. Carbamidomethylation of cysteines was set as a fixed modification.
The identified peptides were filtered with a false detection rate (FDR) of <1%. For protein quantification, the 
log-top3 method was used54. In brief, the average area of the 3 most abundant peptides per protein was normal-
ized to the median of the overall dataset, and this normalized area was used as a measure of protein abundance.
In silico functional and topological analyses of the secretome. The secretome profile linked to each 
treatment was defined as the statistically most abundant proteins identified. Each secretome was evaluated from 
functional and topological points of view, considering its relationship to MI, cardiac regeneration, and its previ-
ous association with the secretome of adipose tissue-derived stem cells12.
Next, we performed an artificial neural network (ANN) analysis to explore connections involved in MI 
and cardiac regeneration, both in global terms and in terms of each individual pathway (see Suppl Material for 
details).
Statistical analysis. Expression levels of cardiac and subcutaneous ATDPCs genes were evaluated with the 
relative fold-change method. Comparisons of control and stimulated groups were evaluated in paired samples 
with the Student’s T-test. Statistical differences were determined from a minimum of 4 independent experiments 
for every surface pattern. Protein quantifications for both cell populations (cardiac and subcutaneous ATDPCs) 
in each condition (stimulated vs. unstimulated and the 3 different patterns) were compared with the Student’s 
T-test.
Proteomic data for each condition was analysed with a pairwise, trimmed, mean normalization method 
adapted from Robinson and Oshlack55. For each pairwise experiment, we compared the differentially expressed 
proteins from control and stimulated replicates. Additionally, among the proteins differentially expressed in car-
diac ATDPCs seeded on horizontal patterned surfaces, we determined the most significant differences in expres-
sion with Fisher’s exact test for small sample sizes56.
All the results are presented as the mean ± SEM. A P-value < 0.05 was considered statistically significant, and 
a P-value < 0.10 was considered a clear tendency. Statistical analyses were performed with SPSS Statistics software 
(version 21, IBM SPSS Inc.).
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